COV vs NAN

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

48LOW

NAN

NANOSONICS FPO [NAN]

48LOW

Score Breakdown

COV NAN
Technical
64
66
Catalyst
55
50
Sentiment
50
50
Fundamental
65
87
Momentum
76
41
Risk Gate
46
40

Key Metrics

COV Metric NAN
$71.9MMarket Cap$1.1B
194KAvg Volume (20d)1.1M
N/AShort Interest+11.9%
$0.90052-Week High$5.080
$0.31052-Week Low$3.210
-4.6%Daily Change+1.9%
$0.525Entry Price$3.700
-49.6%ROE+10.1%
-157.4%Profit Margin+9.9%

Active Signals

COV Signals

●MACD momentum is picking up steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (15 quarters)
●4C filed 2026-01-28
●Strong revenue growth (+373%)
●Small-cap ($20-100M)
●Deeply negative margins (-157%)

NAN Signals

●MACD momentum is picking up steam
●Knocking on the door of resistance — if it punches through, things could get interesting
●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.4x)

Ask Scout AI to compare COV and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
COV Full Analysis → NAN Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).